Literature DB >> 26762335

Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?

Muthiah Vaduganathan1, Ravi B Patel2, Sanjiv J Shah3, Javed Butler4.   

Abstract

The incidence and mechanisms of sudden cardiac death (SCD) among patients with heart failure with reduced ejection fraction have been well characterized. Conversely, limited data are available exploring the landscape of SCD in patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a heterogeneous clinical syndrome of increasing prevalence and is associated with substantial morbidity and mortality. This review will aim to contextualize recent data regarding rates and predictors of SCD in this growing population and to discuss the potential role of pharmacologic and device therapy for prevention of SCD within the at-risk HFpEF subset.

Entities:  

Keywords:  Arrhythmias; Heart failure with preserved ejection fraction; Sudden cardiac death

Mesh：

Year:  2016        PMID： 26762335     DOI： 10.1007/s10741-016-9525-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  57 in total

1.  Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.

Authors:  Tariq Ahmad; Mona Fiuzat; Benjamin Neely; Megan L Neely; Michael J Pencina; William E Kraus; Faiez Zannad; David J Whellan; Mark P Donahue; Ileana L Piña; Kirkwood F Adams; Dalane W Kitzman; Christopher M O'Connor; G Michael Felker
Journal:  JACC Heart Fail       Date:  2014-06       Impact factor: 12.035

Review 2.  Heart failure preserved ejection fraction with coronary artery disease: time for a new classification?

Authors:  Barry Greenberg
Journal:  J Am Coll Cardiol       Date:  2014-04-23       Impact factor: 24.094

3.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

4.  Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease.

Authors:  Ravi B Patel; Jason Ng; Vikram Reddy; Moulin Chokshi; Kishan Parikh; Haris Subacius; Alawi A Alsheikh-Ali; Tuan Nguyen; Mark S Link; Jeffrey J Goldberger; Leonard Ilkhanoff; Alan H Kadish
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-07-24

Review 5.  Prognostic scores in heart failure - Critical appraisal and practical use.

Authors:  Paolo Ferrero; Attilio Iacovoni; Emilia D'Elia; Muthiah Vaduganathan; Antonello Gavazzi; Michele Senni
Journal:  Int J Cardiol       Date:  2015-03-26       Impact factor: 4.164

6.  Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.

Authors:  Sanae Hamaguchi; Shintaro Kinugawa; Mochamad Ali Sobirin; Daisuke Goto; Miyuki Tsuchihashi-Makaya; Satoshi Yamada; Hisashi Yokoshiki; Hiroyuki Tsutsui
Journal:  Circ J       Date:  2012-04-06       Impact factor: 2.993

7.  The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure.

Authors:  Yuhui Zhang; Rongcheng Zhang; Tao An; Yan Huang; Xiao Guo; Shijie Yin; Yunhong Wang; Shiming Ji; Rong Lv; Jian Zhang; Alan Maisel
Journal:  J Card Fail       Date:  2014-10-16       Impact factor: 5.712

8.  Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Scott D Solomon; Duolao Wang; Peter Finn; Hicham Skali; Leonardo Zornoff; John J V McMurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Stuart Pocock; Marc A Pfeffer
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

Review 9.  Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.

Authors:  Muthiah Vaduganathan; Alexander Michel; Kathryn Hall; Claire Mulligan; Savina Nodari; Sanjiv J Shah; Michele Senni; Marco Triggiani; Javed Butler; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

10.  Validation of death certificate diagnosis of out-of-hospital sudden cardiac death.

Authors:  C Iribarren; R S Crow; P J Hannan; D R Jacobs; R V Luepker
Journal:  Am J Cardiol       Date:  1998-07-01       Impact factor: 2.778
View more
  4 in total

Review 1.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Shannon M Dunlay; Véronique L Roger; Margaret M Redfield
Journal:  Nat Rev Cardiol       Date:  2017-05-11       Impact factor: 32.419

Review 2.  Management of Arrhythmias in Heart Failure.

Authors:  Daniele Masarone; Giuseppe Limongelli; Marta Rubino; Fabio Valente; Rossella Vastarella; Ernesto Ammendola; Rita Gravino; Marina Verrengia; Gemma Salerno; Giuseppe Pacileo
Journal:  J Cardiovasc Dev Dis       Date:  2017-02-28

Review 3.  Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update.

Authors:  Daniele Masarone; Giuseppe Limongelli; Ernesto Ammendola; Marina Verrengia; Rita Gravino; Giuseppe Pacileo
Journal:  J Clin Med       Date:  2018-11-10       Impact factor: 4.241

4.  Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats.

Authors:  Claudia M Lucero; David C Andrade; Camilo Toledo; Hugo S Díaz; Katherin V Pereyra; Esteban Diaz-Jara; Karla G Schwarz; Noah J Marcus; Mauricio A Retamal; Rodrigo A Quintanilla; Rodrigo Del Rio
Journal:  Sci Rep       Date:  2020-04-23       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.